Floatz logo

Anti-Cd45

FANCONI ANEMIA

Baylor College of Medicinemonoclonal_antibodyPhase 1/2Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

16 Active assets in the FANCONI ANEMIA cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Porteus, Matthew, MD
Phase 2/3BBB
Fludarabine
Porteus, Matthew, MD
Phase 2/3BBB
Busulphan
Masonic Cancer Center, University of Minnesota
Phase 2/3BBB
CYCLOSPORIN A
Fred Hutchinson Cancer Center
Phase 2BBB
FILGRASTIM
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2BBB

View all 44 →

Same molecule, other indications

Anti-Cd45 is also rated in:

aplastic anemiaDormant
C
Indicative ·
39 / 100
View asset →
hematopoietic and lymphoid cell neoplasmDormant
C
Indicative ·
38 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →